Signaling proteins and pathways affected by flavonoids in leukemia cells

Nutrition and Cancer

Volumn 67, Issue 2, 2015, Pages 238-249

  Liu, Xiaoliang ^a   Ye, Fei ^b   Wu, Josephine ^b   How, Brian ^b   Li, Wei ^a   Zhang, David Y ^b  

^a JILIN UNIVERSITY   (China)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TUBULIN; APIGENIN; B LYMPHOCYTE RECEPTOR; BAICALEIN; CALRETININ; CHRYSIN; CYCLIN B1; CYCLIN D1; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; FLAVONOID; GALANGIN; GENISTEIN; HEAT SHOCK PROTEIN 90; INTERLEUKIN 8; LUTEOLIN; NARINGENIN; NOTCH4 RECEPTOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN; PROTEIN 14 3 3; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL 6; PROTEIN C JUN; PROTEIN KINASE B; PROTEIN P27; SCUTELLARIN; STAT3 PROTEIN; ANTINEOPLASTIC AGENT; CELL CYCLE PROTEIN; TUMOR PROTEIN;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE REGULATION; CELL DIVISION; CELL PROLIFERATION; CHEMICAL STRUCTURE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENCY; HL 60 CELL LINE; HUMAN; HUMAN CELL; IC50; IN VITRO STUDY; JURKAT CELL LINE; K562 CELL LINE; LEUKEMIA CELL; PROTEIN EXPRESSION; PROTEOMICS; SIGNAL TRANSDUCTION; U937 CELL LINE; UPREGULATION; DRUG EFFECTS; LEUKEMIA; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; FLAVONOIDS; HUMANS; LEUKEMIA; NEOPLASM PROTEINS; SIGNAL TRANSDUCTION;

EID: 84924431764     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2015.989372     Document Type: Article

References (42)

1. Brown, P, Hunger, SP, Smith, FO, Carroll, WL, and Reaman, GH: Novel targeted drug therapies for the treatment of childhood acute leukemia. Expert Rev Hematol 2, 145-158, 2009.
2. Brown, DM, Kelly, GE, and Husband, AJ: Flavonoid compounds in maintenance of prostate health and prevention and treatment of cancer. Mol Biotechnol 30, 253-270, 2005.
3. Birt, DF, Hendrich, S, and Wang, W: Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol Ther 90, 157-177, 2001.
4. Spinozzi, F, Pagliacci, MC, Migliorati, G, Moraca, R, Grignani, F, et al.: The natural tyrosine kinase inhibitor genistein produces cell cycle arrest and apoptosis in jurkat T-leukemia cells. Leuk Res 18, 431-439, 1994.
5. Shen, J, Tai, YC, Zhou, J, Wong, CHS, Cheang, PT, et al.: Synergistic antileukemia effect of genistein and chemotherapy in mouse xenograft model and potential mechanism through MAPK signaling. Exp Hematol 35, 75-83, 2007.
6. Uckun, FM, Evans, WE, Forsyth, CJ, Waddick, KG, et al.: Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases. Science 267, 886-891, 1995.
7. Taylor, C. K., Levy, R. M., Elliott, J. C., and Burnett, B. P., The effect of genistein aglycone on cancer and cancer risk: A review of in vitro, preclinical, and clinical studies, Nutr Rev 67, 398-415, 2009.
8. Ma, Z, Otsuyama, K, Liu, S, Abroun, S, Ishikawa, H, et al.: Baicalein, a component of scutellaria radix from huang-lian-jie-du-tang (HLJDT), leads to suppression of proliferation and induction of apoptosis in human myeloma cells. Blood 105, 3312-3318, 2005.
9. Lin, TS, Blum, KA, Fischer, DB,Mitchell, SM, Ruppert, AS, et al.: Flavopiridol, fludarabine, and rituximab in mantle cell lymphoma and indolent B-cell lymphoproliferative disorders. J Clin Oncol 28, 418-423, 2010.
10. Lin, TS, Ruppert, AS, Johnson, AJ, Fischer, B, Heerema, NA, et al.: Phase II study of flavopiridol in relapsed chronic lymphocytic leukemia demonstrating high response rates in genetically high-risk disease. J Clin Oncol 27, 6012-6018, 2009.
11. Herst,PM, Davis, JE,Neeson, P, Berridge, MV, and Ritchie, DS: The anti-cancer drug, phenoxodiol, kills primary myeloid and lymphoid leukemic blasts and rapidly proliferating T cells. Haematologica 94, 928-934, 2009.
12. Plochmann, K, Korte, G, Koutsilieri, E, Richling, E, Riederer, P, et al.: Structure-activity relationships of flavonoid-induced cytotoxicity on human leukemia cells. Arch Biochem Biophys 460, 1-9, 2007.
13. Zhang, DY, Ye, F, Gao, L, Liu, X, Zhao, X, et al.: Proteomics, pathway array and signaling network-based medicine in cancer. Cell Div 4, 20, 2009.
14. Ye, F, Wang, H, Jiang, S,Wu, J, Shao, J, et al.: Quality evaluation of commercial extracts of Scutellaria baicalensis. Nutr Cancer 49, 217-222, 2004.
15. Ye, F, Che, Y, McMillen, E, Gorski, J, Brodman, D, et al.: The effect of scutellaria baicalensis on the signaling network in hepatocellular carcinoma cells. Nutr Cancer 61, 530-537, 2009.
16. Banerjee, S, Li, Y, Wang, Z, and Sarkar, FH: Multi-targeted therapy of cancer by genistein. Cancer Lett 269, 226-242, 2008.
17. Ramanouskaya, TV, Smolnykova, VV, and Grinev, V: Relationship between structure and antiproliferative, proapoptotic, and differentiation effects of flavonoids on chronic myeloid leukemia cells. Anticancer Drugs 20, 573-583, 2009.
18. Herst,PM, Davis, JE,Neeson, P, Berridge, MV, and Ritchie, DS: The anti-cancer drug, phenoxodiol, kills primary myeloid and lymphoid leukemic blasts and rapidly proliferating T cells. Haematologica 94, 928-934, 2009.
19. Vargo, MA, Voss, OH, Poustka, F, Cardounel, AJ, Grotewold, E, et al.: Apigenin-induced-apoptosis is mediated by the activation of PKCdelta and caspases in leukemia cells. Biochem Pharmacol 72, 681-692, 2006.
20. Jin, CY, Park, C, Lee, JH, Chung, KT, Kwon, TK, et al.: Naringenininduced apoptosis is attenuated by bcl-2 but restored by the small molecule bcl-2 inhibitor, HA 14-1, in human leukemia U937 cells. Toxicol in. Vitro 23, 259-265, 2009.
21. Bestwick, CS and Milne, L: Influence of galangin on HL-60 cell proliferation and survival. Cancer Lett 243, 80-89, 2006.
22. Zhang, D, Tai, YC, Wong, CH, Tai, LK, Koay, ES, et al.: Molecular response of leukemia HL-60 cells to genistein treatment, a proteomics study. Leuk Res 31, 75-82, 2007.
23. Plochmann, K, Korte, G, Koutsilieri, E, Richling, E, Riederer, P, et l.: Structure-activity relationships of flavonoid-induced cytotoxicity on human leukemia cell. Arch Biochem Biophys 460, 1-9, 2007.
24. Kitagawa, S, Nabekura, T, Takahashi, T, Nakamura, Y, Sakamoto, H, et al.: Structure-activity relationships of the inhibitory effects of flavonoids on P-glycoprotein-mediated transport in KB-C2 cells. Biol Pharm Bull 28, 2274-2278, 2005.
25. DortaDJ, Pigoso, AA, Mingatto, FE, Rodrigues, T, Prado, IM, et al.: The interaction of flavonoids with mitochondria: effects on energetic processes. Chem Biol Interact 152, 67-78, 2005.
26. Ohishi, K, Katayama, N, Shiku, H, Varnum-Finney, B, and Bernstein, ID: Notch signalling in hematopoiesis. Semin Cell Dev Biol 14, 143-150, 2003.
27. Sandy, AR and Maillard, I: Notch signaling in the hematopoietic system. Expert Opin Biol Ther 9, 1383-1398, 2009.
28. Rao, SS, Liberator, J, HardwickCD, Dai JS, et al.: Inhibition of NOTCH signaling by gamma secretase inhibitor engages the RB pathway and elicits cell cycle exit in T-cell acute lymphoblastic leukemia cells. Cancer Res 69, 3060-3068, 2009.
29. Li, GH, Fan, YZ, Liu, XW, Zhang, BF, Yin, DD, et al.: Notch signaling maintains proliferation and survival of the HL60 human promyelocytic leukemia cell line and promotes the phosphorylation of the RB protein. Mol Cell Biochem 340, 7-14, 2010.
30. JohnsonT. L., Lai, M. B., Lai, J. C., and Bhushan, A., Inhibition of cell proliferation and MAP kinase and akt pathways in oral squamous cell carcinoma by genistein and biochanin A, Evid Based. Complement. Alternat Med. (2008).
31. Gao, J, Tian, J, Lv, Y, Shi, F, Kong, F, et al.: Leptin induces functional activation of cyclooxygenase-2 through JAK2/STAT3, MAPK/ERK, and PI3K/AKT pathways in human endometrial cancer cells. Cancer Sci 100, 389-395, 2009.
32. Nam, TW, Yoo, CI, Kim, HT, Kwon, CH, Park, JY, et al.: The flavonoid quercetin induces apoptosis and inhibits migration through a MAPK-dependent mechanism in osteoblasts. J BoneMinerMetab 26, 551-560, 2008.
33. Shukla, S and Gupta, S: Apigenin-induced cell cycle arrest is mediated by modulation of MAPK, PI3K-akt, and loss of cyclin D1 associated retinoblastoma dephosphorylation in human prostate cancer cells. Cell Cycle 6, 1102-1114, 2007.
34. Zhou, QM, Wang, S, Zhang, H, Lu, YY, Wang, XF, et al.: The combination of baicalin and baicalein enhances apoptosis via the ERK/p38 MAPK pathway in human breast cancer cells. Acta Pharmacol Sin 30, 1648-1658, 2009.
35. Lee, HZ, Leung, HW, Lai, MY, and Wu, CH: Baicalein induced cell cycle arrest and apoptosis in human lung squamous carcinoma CH27 cells. Anticancer Res 25, 959-964, 2005.
36. Hwang, KA, Kang, NH, Yi, BR, Lee, HR, Park, MA, et al.: Genistein, a soy phytoestrogen, prevents the growth of BG-1 ovarian cancer cells induced by 17beta-estradiol or bisphenol A via the inhibition of cell cycle progression. Int J Oncol 42, 733-740, 2013.
37. Zhang, Y., Song, L., Cai, L., Wei, R., Hu, H., and Jin, W., Effects of baicalein on apoptosis, cell cycle arres, 2013.
38. Vidya Priyadarsini, R, Senthil Murugan, R, Maitreyi, S, Ramalingam, K, Karunagaran, D, et al.: The flavonoid quercetin induces cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells through p53 induction and NF-kappaB inhibition. Eur J Pharmacol 649, 84-91, 2010.
39. Lee, HZ, Leung, HW, Lai, MY, and Wu, CH: Baicalein induced cell cycle arrest and apoptosis in human lung squamous carcinoma CH27 cells. Anticancer Res 25, 959-964, 2005.
40. Davis, JN, Singh, B, Bhuiyan, M, and Sarkar, F: Genistein-induced upregulation of p21WAF1, downregulation of cyclin B, and induction of apoptosis in prostate cancer cells. Nutr Cancer 32, 123-131, 1998.
41. Liu, S, Ma, Z, Cai, H, Li, Q, Rong, W, et al.: Inhibitory effect of baicalein on IL-6-mediated signaling cascades in human myeloma cells. Eur J Haematol 84, 137-144, 2010.
42. Lian, F, Bhuiyan, M, Li, YW, Wall, N, Kraut, M, et al.: Genisteininduced G2-M arrest, p21WAF1 upregulation, and apoptosis in a nonsmall-cell lung cancer cell line. Nutr Cancer 31, 184-191, 1998.